Business Context and Reporting Period
Ohmyhome Limited, a foreign private issuer based in Singapore, filed Form 6-K for the month of July 2026. The filing reports the entry into a material definitive agreement on July 17, 2026, involving a private placement of securities.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial data disclosed relates to the capital raise:
- Gross Proceeds: Approximately $1.6 million (before customary expenses).
- Securities Issued: 5,333,331 Class A ordinary shares and 5,333,331 warrants.
- Price: $0.30 per share and one associated warrant.
- Use of Proceeds: Working capital and general corporate purposes.
Material Changes
The material change reported is the execution of a Securities Purchase Agreement with several "non-U.S. Persons" under Regulation S. This transaction increases the company's share count and warrant obligations. The filing does not provide comparative financial data against a prior period to quantify changes in operational performance.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the proceeds for working capital and general corporate purposes. The transaction is expected to close on July 17, 2026.
Warrant Terms and Risks:
- Exercise Price: Initial price of $0.30 per share, with a floor of $0.10 per share.
- Expiration: Warrants expire five years from the Initial Exercise Date.
- Exchange Feature: Starting on the 7th calendar day following issuance, holders may exchange warrants for shares at a ratio of 9 shares for every 1 warrant share underlying the portion exercised.
- Regulatory Status: Securities were sold in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act of 1933 and Regulation S.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received after deducting customary expenses.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants or restrictions.
- Assess the potential dilution impact of the 9:1 warrant exchange feature on existing shareholders.
- Confirm the identity of the "non-U.S. Persons" purchasing the securities to evaluate investor quality.
- Check subsequent filings for updates on the utilization of the $1.6 million in working capital.